The rising interest in successful weight management has led to considerable exploration into cutting-edge treatments. Currently, Retatrutide, a combined -action glucose-dependent insulinotropic polypeptide (GIP) and peptide receptor activator , has exhibited promising results in medical trials, suggesting potential for significant weight loss . The